These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22744710)

  • 21. [A case of malignant peritoneal mesothelioma diagnosed with laparoscopic biopsy].
    Yagi Y; Maeda T; Yoshimitsu Y; Sakuma H
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):995-7. PubMed ID: 25132032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
    De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N
    Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
    Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
    Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: a future drug against a fatal neoplastic disease?
    Tomasetti M; Gellert N; Procopio A; Neuzil J
    Int J Cancer; 2004 May; 109(5):641-2. PubMed ID: 14999768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management strategies for peritoneal mesothelioma.
    Turaga KK; Deraco M; Alexander HR
    Int J Hyperthermia; 2017 Aug; 33(5):579-581. PubMed ID: 28664790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.
    Lee YK; Jun HJ; Nahm JH; Lim TS; Park JS; Ahn JB; Rha SY; Chung HC; Oh HE; Song JS; Yang WI; Kim HS
    Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
    Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
    Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Well-differentiated papillary mesothelioma of the peritoneum. Rare, but prognostically important differential diagnosis].
    Lammer F; Scherrer C; Häcki WH
    Schweiz Med Wochenschr; 1991 Jun; 121(25):954-6. PubMed ID: 1862312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonic invasion of malignant peritoneal mesothelioma.
    Chan CC; Isomoto H; Ohnita K; Mizuta Y; Kohno S; Hayashi T
    Gastrointest Endosc; 2010 Feb; 71(2):397-8; discussion 398. PubMed ID: 19913225
    [No Abstract]   [Full Text] [Related]  

  • 30. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
    Lee M; Alexander HR; Burke A
    Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells.
    Tsukiji H; Takeshima Y; Amatya VJ; Kushitani K; Inai K
    Histopathology; 2010 Jun; 56(7):969-74. PubMed ID: 20636799
    [No Abstract]   [Full Text] [Related]  

  • 32. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic mesothelioma of the peritoneum. A report of three cases.
    Villaschi S; Autelitano F; Santeusanio G; Balistreri P
    Am J Clin Pathol; 1990 Dec; 94(6):758-61. PubMed ID: 1700878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Well-differentiated papillary mesothelioma: report of a case].
    Guo J; Wen GY
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):431-2. PubMed ID: 17822637
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Mucin-positive' epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall.
    Cook DS; Attanoos RL; Jalloh SS; Gibbs AR
    Histopathology; 2000 Jul; 37(1):33-6. PubMed ID: 10931216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.
    Vlasveld LT; Taal BG; Kroon BB; Gallee MP; Rodenhuis S
    Cancer Chemother Pharmacol; 1992; 29(5):405-8. PubMed ID: 1551180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal mesothelioma: current status and future directions.
    Chua TC; Chong CH; Morris DL
    Surg Oncol Clin N Am; 2012 Oct; 21(4):635-43. PubMed ID: 23021721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results.
    Miliauskas S; Zemaitis M; Pranys D
    J Thorac Oncol; 2009 Mar; 4(3):435-6. PubMed ID: 19247093
    [No Abstract]   [Full Text] [Related]  

  • 39. Metastatic peritoneal mesothelioma in the setting of recurrent ascites: a case report.
    Samedi V; White S; Zimarowski MJ; Harris A; Saffitz J; Wang HH
    Diagn Cytopathol; 2010 Sep; 38(9):675-81. PubMed ID: 20049974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy maintenance: an option for prolonged survival in malignant peritoneal mesothelioma?
    Hofer S; Sasse B; Scheffel H
    Acta Oncol; 2010; 49(1):122-4. PubMed ID: 20104656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.